• Diclofenac: Non-Selective COX Inhibitor in Intestinal Organo

  2026-06-30

  Diclofenac empowers translational inflammation and pharmacokinetic research using hiPSC-derived intestinal organoids, bridging the gap between bench models and human relevance. This article details optimized workflows, troubleshooting insights, and APExBIO's product advantages for cyclooxygenase inhibition assays in next-generation in vitro systems.

• Protease Inhibitor Cocktail EDTA-Free: Powering Reliable Pro

  2026-06-30

  Protect labile proteins from degradation with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), engineered for maximal compatibility with sensitive phosphoprotein workflows and immunoassays. This guide reveals hands-on protocols, advanced troubleshooting, and the latest experimental insights, ensuring data integrity from bench to publication.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Use Guide

  2026-06-29

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses the challenge of sensitive, specific detection of rabbit IgG in fluorescence-based immunoassays, including immunofluorescence, IHC, and ICC. It is not suitable for use with non-rabbit primary antibodies or for diagnostic applications.

• A23187, Free Acid: Reframing Calcium Ionophore Strategy in T

  2026-06-29

  Explore how A23187, free acid, a benchmark calcium ionophore, is redefining strategies for translational research through mechanistic insight and protocol optimization. This article bridges cutting-edge in vitro methodologies with actionable guidance for drug discovery and systems biology, drawing on authoritative sources and APExBIO’s proven solutions.

• Syringin Sensitizes RCC to Sunitinib via EGFR/PI3K/Akt Inhib

  2026-06-28

  This article examines a recent study identifying Syringin as a bioactive natural product that inhibits renal cell carcinoma (RCC) cell growth and enhances sensitivity to sunitinib by modulating the EGFR/PI3K/Akt pathway. The findings highlight mechanistic advances and practical implications for overcoming drug resistance in RCC using natural compound approaches.

• Elevating Cell Viability Assays: Translational Insights with

  2026-06-27

  This thought-leadership article explores the mechanistic and strategic dimensions of dual-fluorescence live-dead cell staining, contextualizing the APExBIO Live-Dead Cell Staining Kit within advanced translational workflows—from biomaterial evaluation to diabetic wound healing. Drawing on recent advances in hydrogel therapeutics and robust protocol recommendations, the article bridges fundamental viability assessment with new frontiers in regenerative medicine.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein Wo

  2026-06-26

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO delivers unmatched protein preservation in workflows sensitive to divalent cations. Its robust, EDTA-free formulation ensures compatibility with phosphorylation analysis and multi-protein assays—empowering researchers to achieve high-fidelity results where conventional protease inhibitors fall short.

• 2X Taq PCR Master Mix: Streamlined PCR for Genotyping & TA C

  2026-06-26

  Accelerate genotyping and TA cloning with the 2X Taq PCR Master Mix (with dye)—a robust, ready-to-use solution that simplifies workflows and reduces error risk. Direct gel loading and reliable adenine overhangs make it ideal for high-throughput and precision DNA analysis.

• A-769662 and the Redefinition of AMPK’s Role in Energy Stres

  2026-06-25

  This thought-leadership article integrates new mechanistic insights on AMPK’s dual function in autophagy suppression and energy homeostasis, providing translational researchers with strategic guidance for leveraging A-769662 as a precision AMPK activator. Drawing upon recent landmark studies and practical workflow recommendations, it positions APExBIO’s A-769662 as a keystone compound for dissecting metabolic signaling, challenging outdated paradigms, and advancing the rigor of metabolic disease research.

• Protease Inhibitor Cocktail EDTA-Free: Optimizing Protein Ex

  2026-06-25

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO streamlines protein extraction and analysis in workflows where preservation of phosphorylation states and divalent cation integrity are paramount. Its EDTA-free, broad-spectrum formulation unlocks advanced proteomics, immunoassay, and phosphorylation-sensitive applications with unmatched sample protection.

• 6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I

  2026-06-24

  The reference study unveils a novel antiviral action for 6-thioguanine, demonstrating that it significantly inhibits Enterovirus 71 (EV71) replication by downregulating BIRC3 and disrupting autophagy in infected cells. These mechanistic insights inform the development of targeted therapies for EV71-associated diseases and highlight the value of chemical modulation in infectious disease research.

• CHI3L1-IN-5 (Compound Z17): Optimizing Neuroinflammation Ass

  2026-06-23

  CHI3L1-IN-5 (Compound Z17) empowers researchers to dissect CHI3L1-mediated NF-κB inflammatory pathways with unprecedented specificity and CNS penetration. Its dual-action on inflammatory signaling and astrocyte lysosomal repair enables reproducible, high-impact neurodegeneration workflows.

• HA Tag Peptide: Strategic Tagging for Exosome Pathways

  2026-06-23

  This thought-leadership article explores the strategic deployment of the Influenza Hemagglutinin (HA) Peptide as an epitope tag in translational research, with a focus on its role in elucidating novel exosome biogenesis mechanisms. Integrating mechanistic insights from ESCRT-independent exosome pathways with practical guidance for immunoprecipitation and protein interaction studies, we offer a roadmap for optimizing experimental workflows and accelerating clinical translation.

• Wnt Agonist 1 (BML-284): Applied Protocols and Troubleshooti

  2026-06-22

  Wnt agonist 1 (BML-284) accelerates precision activation of the canonical Wnt signaling pathway, enabling robust cellular differentiation and developmental biology research. This guide delivers actionable protocols, advanced workflows, and troubleshooting strategies—grounded in recent mechanistic findings and supported by APExBIO’s high-purity supply.

• Cy5.5 NHS Ester (Non-Sulfonated): Precision NIR Labeling in

  2026-06-22

  Discover how Cy5.5 NHS ester (non-sulfonated) is advancing near-infrared labeling for challenging biological matrices, with a focus on molecular complexity, assay design, and translational imaging. This in-depth analysis reveals scientific nuances and practical strategies you won’t find elsewhere.

14542 records 3/970 page Previous Next 12345 下5页 Last page